Amanote Research
Register
Sign In
330. Comparing Dual AAV Vector Strategy Efficiencies for Gene Therapy in Vitro and in Vivo
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)34665-2
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2013
Authors
Unknown
Publisher
Elsevier BV
Related search
308. Inclusion of Heterologous ITRs in Dual AAV Vectors for Retinal Gene Therapy
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
309. Optimization of Dual AAV Vectors for Gene Therapy of Inherited Retinal Diseases
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
429. AAV/B7H1-Gene Delivery Lowers Th1 Cytotoxic T Lymphocyte Response in Vitro and Atherogenesis in Vivo
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Trans-Ocular Electric Current in Vivo Enhances AAV-mediated Retinal Gene Transduction After Intravitreal Vector Administration
Molecular Therapy - Methods and Clinical Development
Molecular Medicine
Genetics
Molecular Biology
Targeted Adenoviral Vector Demonstrates Enhanced Efficacy for in Vivo Gene Therapy of Uterine Leiomyoma
Reproductive Sciences
Gynecology
Obstetrics
Role of the Vector Genome and Underlying Factor IX Mutation in Immune Responses to AAV Gene Therapy for Hemophilia B
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
A Lentiviral Gene Therapy Strategy for the in Vitro Production of Feline Erythropoietin
PLoS ONE
Multidisciplinary
Dual-Regulated Lentiviral Vector for Gene Therapy of X-Linked Chronic Granulomatosis
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Dual-Vector Prodrug Activator Gene Therapy Using Retroviral Replicating Vectors
Cancer Gene Therapy
Cancer Research
Molecular Medicine
Molecular Biology
